A new AHRQ evidence review conducted in partnership with the Patient-Centered Outcomes Research Institute (PCORI) identified several therapies that decrease post-traumatic stress disorder (PTSD) and depression symptoms. Those therapies include psychotherapies, such as cognitive behavioral exposure therapies and cognitive behavioral therapies with mixed components, and certain medications, such as paroxetine, fluoxetine and venlafaxine. According to the report, however, most studies had limited information about adverse events related to therapy or medications. Evidence was insufficient on how treatments compare with each other or to determine how treatment choices might be guided by the type of trauma experienced. About 8 million adults have PTSD during a given year, according to data from the National Center for PTSD at the Department of Veterans Affairs. Access the report, which was funded by PCORI.
Homelessness in America | Chamber of Commerce
Hace 10 horas